LC-MS Solutions Simplify Sample Preparation Time and Maximize Mass Spec Throughput
SAN JOSE, Calif. (November 11, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability of a new technical library of liquid chromatography-mass spectrometry (LC-MS) solutions for endocrine drug analysis in clinical research, including methods showcasing the ability of automated sample preparation and multiplexing to reduce sample preparation time and maximize mass spectrometer throughput.
Thermo Fisher Scientific has launched a technical library of liquid chromatography-mass spectrometry (LC-MS) solutions for endrocine analysis in clinical research
The regularly updated technical library, available at thermoscientific.com/lcmsendo, comprises detailed publications from Thermo Fisher's dedicated global clinical research team, which develops faster and more analytically sensitive methods for endocrine drug analysis for its research clients. The new library is a comprehensive resource containing application notes, webinars, technical posters, case studies, videos and web resources for numerous applications.
"We designed the LC-MS technical library for endocrine drug analysis to help laboratory managers and technicians better understand the power of LC-MS technology for clinical research. We believe what they learn from this great resource will help maximize their sample throughput, improve turnaround time and reduce overall analysis cost, without compromising data quality for drug analysis," said Ian Jardine, vice president of global R&D, Thermo Fisher.
The technical library includes the latest applications utilized for the analysis of endocrine drugs in clinical research, including: - Immunoaffinity for research analysis of 1,25D - Automated online sample preparation for time savings - UHPLC for higher throughput - Triple stage quadrupole for necessary LOQ and dynamic range - High-resolution, accurate mass for difficult endogenous molecules
The online technical library, designed as a knowledge transfer tool, is available free of charge at thermoscientific.com/lcmsendo.
For Research Use Only. Not for use in diagnostic procedures.
For the latest information about Thermo Fisher Scientific solutions and the wide range of applications for endocrine drug analysis, please call +1 800 532 4752, e-mail [email protected] or visit www.thermoscientific.com/ms
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com
Media Contact Information:
Name: Laura Browne
Phone: +44 1477 539539
Email: [email protected]
Secondary Contact Information:
Name: Stephanie Kubina
Phone: +1 (408) 965-6022
Email: [email protected]